August 02 2019 GeoVax Issues Shareholder Update Letter July 30 2019 GeoVax Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 GeoVax Presents HIV Vaccine Study Data July 16 2019 GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data × About GeoVax Company Management Board of Directors Scientific Advisory Board Our Technology Technology Overview Publications Investors Corporate Profile News SEC Filings GeoVax Stock Information Corporate Governance Analyst Coverage Investor FAQ's Product Pipeline Pipeline Summary Immuno-Oncology Infectious Diseases Collaborators Don't miss a thing! Subscribe to our newsletter Sign up Message
July 30 2019 GeoVax Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 GeoVax Presents HIV Vaccine Study Data July 16 2019 GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data ×
July 29 2019 GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 GeoVax Presents HIV Vaccine Study Data July 16 2019 GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data ×
July 24 2019 GeoVax Presents HIV Vaccine Study Data July 16 2019 GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data ×
